25 XP 0   0   10  
0coffee
Main menu
3rd party ad coffee SUPPORTERis ad-free.

Piramal Pharma Limited
Buy, Hold or Sell?

Let's analyze Piramal Pharma Limited together

I guess you are interested in Piramal Pharma Limited. Buy, hold or sell? I don't know! However, I do recommend doing research before doing anything. I will help you with that.

I'm going to help you getting a better view of Piramal Pharma Limited. At the end you don't have to ask anyone for trading advice. You can make your own decision, with more confidence, the odds in your favor, backed by data.

Get notifications about Piramal Pharma Limited

I send you an email if I find something interesting about Piramal Pharma Limited.

1. Quick Overview

1.1. Quick analysis of Piramal Pharma Limited (30 sec.)










1.2. What can you expect buying and holding a share of Piramal Pharma Limited? (30 sec.)

How much money do you get?

How much money do you get?
INR0.00
When do you have the money?
1 year
How often do you get paid?
75.0%

What is your share worth?

Current worth
INR59.94
Expected worth in 1 year
INR94.43
How sure are you?
100.0%

+ What do you gain per year?

Total Gains per Share
INR34.49
Return On Investment
13.8%

For what price can you sell your share?

Current Price per Share
INR250.15
Expected price per share
INR209.50 - INR307.90
How sure are you?
50%
3rd party ad coffee SUPPORTERis ad-free.

2. Detailed Analysis

2.1. Valuation of Piramal Pharma Limited (5 min.)




Live pricePrice per Share (EOD)
INR250.15
Intrinsic Value Per Share
INR-22.98 - INR-27.30
Total Value Per Share
INR36.96 - INR32.65

2.2. Growth of Piramal Pharma Limited (5 min.)




Is Piramal Pharma Limited growing?

Current yearPrevious yearGrowGrow %
How rich?$933.5m$799.2m$134.2m14.4%

How much money is Piramal Pharma Limited making?

Current yearPrevious yearGrowGrow %
Making money$2.1m-$22m$24.1m1,146.4%
Net Profit Margin0.2%-2.6%--

How much money comes from the company's main activities?

2.3. Financial Health of Piramal Pharma Limited (5 min.)




3rd party ad coffee SUPPORTERis ad-free.

3. Summary and Key Metrics

3.1. What can you expect buying and holding a share of Piramal Pharma Limited?

Welcome investor! Piramal Pharma Limited's management wants to use your money to grow the business. In return you get a share of Piramal Pharma Limited.

First you should know what it really means to hold a share of Piramal Pharma Limited. And how you can make/lose money.

Speculation

The Price per Share of Piramal Pharma Limited is INR250.15. The market price reflects what other people think it is worth; not what it's really worth. Your job is to find out if the market price is fair, overpriced, or underpriced. I will help you with that.

If you buy blind, there is a 50% chance of making or losing money by selling the stock in the future. However, we can look at a few things to determine the odds in our favor:

  • The fundamentals: the financial health trends of Piramal Pharma Limited.
  • The technials: based on market psychology, we can make a calculated estimate of what the price will do in the future. We can do this through technical analysis. We can calculate the probabilities and the expected value (millionaire math). That's called speculation.
  • The book value: what is the market price compared to it's book value.

Investing

If you really want to invest in Piramal Pharma Limited, you will have to let go of the thought of selling in the future. If you have to sell the share for less than you bought it, it can still be a good investment. Focus on what it means to hold the stock forever:

  • You own a part of the company. The equity of this part can grow or shrink. The current Book Value per Share is INR59.94. Based on the TTM, the Book Value Change Per Share is INR8.62 per quarter. Based on the YOY, the Book Value Change Per Share is INR12.93 per quarter.
  • You may receive quarterly/yearly dividend in the form of additional shares.
  • You may receive quarterly/yearly dividend in the form of cash. Based on the TTM the Dividend per Share is INR0.00 per quarter.
Based on historical numbers we can estimate the returns while holding a share of Piramal Pharma Limited.

How much money are you going to get?

 MRQTTMYOY5Y10Y
 INR% of Price per ShareINR% of Price per ShareINR% of Price per ShareINR% of Price per ShareINR% of Price per Share
Usd Eps0.000.0%0.000.0%-0.020.0%0.020.0%0.020.0%
Usd Book Value Change Per Share0.100.0%0.100.0%0.150.1%0.180.1%0.180.1%
Usd Dividend Per Share0.000.0%0.000.0%0.010.0%0.000.0%0.000.0%
Usd Total Gains Per Share0.100.0%0.100.0%0.160.1%0.180.1%0.180.1%
Usd Price Per Share1.52-1.52-0.81-0.58-0.58-
Price to Earnings Ratio954.69-954.69--48.45-226.56-226.56-
Price-to-Total Gains Ratio14.95-14.95-5.09-10.02-10.02-
Price to Book Ratio2.15-2.15-1.33-0.87-0.87-
Price-to-Total Gains Ratio14.95-14.95-5.09-10.02-10.02-

When do you get the money?

Usd Investment
$.00
Usd Price Per Share2.95177
Number of shares338
Gains per QuarterTrailing 12 Months5 Year
Usd Dividend Per Share0.000.00
Usd Book Value Change Per Share0.100.18
Usd Total Gains Per Share0.100.18
Gains per Quarter (338 shares)34.3961.03
Gains per Year (338 shares)137.54244.12
YearsReturn on Investment (TTM)Return on Investment (5Y)
 DividendBook Value gainTotal gainsDividendBook Value gainTotal gains
Broker costs---10---10
101381285239234
2027526610478478
3041340415717722
4055054220956966
506886802511951210
608258183014341454
709639563516741698
80110010944019131942
90123812324521522186
100137513705023912430

How sure are you?

Based on the past periods, how sure are you to get value out of your investment.

Linear %
 Trailing 12 Months3Y5 Year10 YearALLTIME
  % % % % %
Earnings Per Share1.00.00.0100.0%2.01.00.066.7%3.01.00.075.0%3.01.00.075.0%3.01.00.075.0%
Book Value Change Per Share1.00.00.0100.0%3.00.00.0100.0%4.00.00.0100.0%4.00.00.0100.0%4.00.00.0100.0%
Dividend per Share0.00.01.00.0%2.00.01.066.7%3.00.01.075.0%3.00.01.075.0%3.00.01.075.0%
Total Gains per Share1.00.00.0100.0%3.00.00.0100.0%4.00.00.0100.0%4.00.00.0100.0%4.00.00.0100.0%
3rd party ad coffee SUPPORTERis ad-free.

3.2. Key Performance Indicators

The key performance indicators of Piramal Pharma Limited compared to the Most Recent Quarter (MRQ).

 End of day+/-Most Recent QuarterTrailing 12 Months+/-Year-Over-Year+/-5 Year+/-10 Year+/-
Book Value Change Per Share--8.6218.6210%12.927-33%14.986-42%14.986-42%
Book Value Per Share--59.94259.9420%51.321+17%45.182+33%45.182+33%
Current Ratio--1.2511.2510%1.258-1%1.250+0%1.250+0%
Debt To Asset Ratio--0.4830.4830%0.534-9%0.400+21%0.400+21%
Debt To Equity Ratio--0.9350.9350%1.144-18%0.726+29%0.726+29%
Dividend Per Share----0%0.508-100%0.316-100%0.316-100%
Eps--0.1350.1350%-1.413+1146%1.475-91%1.475-91%
Free Cash Flow Per Share---1.167-1.1670%-3.643+212%-1.143-2%-1.143-2%
Free Cash Flow To Equity Per Share---0.868-0.8680%2.553-134%10.709-108%10.709-108%
Gross Profit Margin---16.067-16.0670%2.720-691%-3.009-81%-3.009-81%
Intrinsic Value_10Y_max---27.295--------
Intrinsic Value_10Y_min---22.982--------
Intrinsic Value_1Y_max---1.743--------
Intrinsic Value_1Y_min---1.694--------
Intrinsic Value_3Y_max---5.993--------
Intrinsic Value_3Y_min---5.647--------
Intrinsic Value_5Y_max---11.155--------
Intrinsic Value_5Y_min---10.181--------
Market Cap330155478502.400+48%170126089062.400170126089062.4000%90342364595.200+88%65117113414.400+161%65117113414.400+161%
Net Profit Margin--0.0020.0020%-0.026+1307%0.073-97%0.073-97%
Operating Margin--0.0560.0560%0.033+71%0.055+2%0.055+2%
Operating Ratio--0.9440.9440%1.007-6%0.925+2%0.925+2%
Pb Ratio4.173+48%2.1502.1500%1.334+61%0.871+147%0.871+147%
Pe Ratio1852.724+48%954.692954.6920%-48.451+105%226.560+321%226.560+321%
Price Per Share250.150+48%128.900128.9000%68.450+88%49.338+161%49.338+161%
Price To Free Cash Flow Ratio-214.331-94%-110.443-110.4430%-18.788-83%-32.308-71%-32.308-71%
Price To Total Gains Ratio29.015+48%14.95114.9510%5.095+193%10.023+49%10.023+49%
Quick Ratio--0.6650.6650%0.852-22%1.008-34%1.008-34%
Return On Assets--0.0010.0010%-0.013+1203%0.035-97%0.035-97%
Return On Equity--0.0020.0020%-0.028+1322%0.047-95%0.047-95%
Total Gains Per Share--8.6218.6210%13.435-36%15.302-44%15.302-44%
Usd Book Value--933541660.000933541660.0000%799273000.000+17%703658485.000+33%703658485.000+33%
Usd Book Value Change Per Share--0.1020.1020%0.153-33%0.177-42%0.177-42%
Usd Book Value Per Share--0.7070.7070%0.606+17%0.533+33%0.533+33%
Usd Dividend Per Share----0%0.006-100%0.004-100%0.004-100%
Usd Eps--0.0020.0020%-0.017+1146%0.017-91%0.017-91%
Usd Free Cash Flow---18176720.000-18176720.0000%-56741480.000+212%-17806200.000-2%-17806200.000-2%
Usd Free Cash Flow Per Share---0.014-0.0140%-0.043+212%-0.013-2%-0.013-2%
Usd Free Cash Flow To Equity Per Share---0.010-0.0100%0.030-134%0.126-108%0.126-108%
Usd Market Cap3895834646.328+48%2007487850.9362007487850.9360%1066039902.223+88%768381938.290+161%768381938.290+161%
Usd Price Per Share2.952+48%1.5211.5210%0.808+88%0.582+161%0.582+161%
Usd Profit--2102760.0002102760.0000%-22002280.000+1146%22975190.000-91%22975190.000-91%
Usd Revenue--964196880.000964196880.0000%835622900.000+15%627962665.000+54%627962665.000+54%
Usd Total Gains Per Share--0.1020.1020%0.159-36%0.181-44%0.181-44%
 EOD+5 -3MRQTTM+0 -0YOY+22 -145Y+11 -2510Y+11 -25

3.3 Fundamental Score

Let's check the fundamental score of Piramal Pharma Limited based on Penke's default stock scanner.

Penke's Stock Scanner

  
  
IndicatorConditionValue
Price to Earnings Ratio (EOD)Between0-151,852.724
Price to Book Ratio (EOD)Between0-14.173
Net Profit Margin (MRQ)Greater than00.002
Operating Margin (MRQ)Greater than00.056
Quick Ratio (MRQ)Greater than10.665
Current Ratio (MRQ)Greater than11.251
Debt to Asset Ratio (MRQ)Less than10.483
Debt to Equity Ratio (MRQ)Less than10.935
Return on Equity (MRQ)Greater than0.150.002
Return on Assets (MRQ)Greater than0.050.001
Total5/10 (50.0%)

3.4 Technical Score

Let's check the technical score of Piramal Pharma Limited based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5049.107
Ma 20Greater thanMa 50262.034
Ma 50Greater thanMa 100239.891
Ma 100Greater thanMa 200208.041
OpenGreater thanClose248.300
Total3/5 (60.0%)

4. In-depth Analysis

4.1 About Piramal Pharma Limited

Piramal Pharma Limited operates as a pharmaceutical company in North America, Europe, Japan, India, and internationally. The company offers a portfolio of pharmaceutical products and services through global development and manufacturing facilities and distribution network. It also operates contract development and manufacturing organization that provides services across the spectrum of the drug life cycle, including discovery, development, and commercial manufacturing of drug substances and products; complex hospital generics business which offers inhalation anesthetics, intrathecal therapy for spasticity management, injectable pain and anesthesia drugs, and other generic and specialty products; and India consumer healthcare business comprising analgesics, skin care, vitamin/mineral supplement, kids' wellness, digestives, women's health, and hygiene and protection. The company was incorporated in 2020 and is based in Mumbai, India.

Fundamental data was last updated by Penke on 2024-11-03 00:36:04.

4.2 In-depth Summary

4.2.1. Financial Health Summary

Profitability Details
 Compared to previous yearCompared to industry
The company is not making a profit/loss.
Using its assets, the company is inefficient in making profit.
Using its investors money, the company is inefficient in making profit.
Operating Efficiency Details
 Compared to previous yearCompared to industry
The company is operating less efficient.
The company is less efficient in keeping operating costs low.
Liquidity Details
 Compared to previous yearCompared to industry
The company is just able to pay all its short-term debts.
The company is just not able to pay all its short-term debts with the most liquid assets.
Solvency Details
 Compared to previous yearCompared to industry
The company is very able to pay all its debts by selling its assets.
The company is very able to pay all its debts with equity.

4.2.2. Valuation Summary

Valuation Details
 Compared to previous yearCompared to industry
Based on the equity, the company is underpriced.
Based on the earnings, the company is expensive.
Based on how much money comes from the company's main activities, the company is expensive.
3rd party ad coffee SUPPORTERis ad-free.

4.3 Financial Health

4.3.1. Profitability

4.3.1 Profitability
4.3.1.1. Net Profit Margin

Measures how much net profit Piramal Pharma Limited earns for each ₹1 of revenue.

  • Above 10% is considered healthy but always compare Piramal Pharma Limited to the Drug Manufacturers - Specialty & Generic industry mean.
  • A Net Profit Margin of 0.2% means that ₹0.00 for each ₹1 in revenue is generated as profit.

Let's take a look of the Net Profit Margin trends of Piramal Pharma Limited:

  • The MRQ is 0.2%. The company is not making a profit/loss.
  • The TTM is 0.2%. The company is not making a profit/loss.
Trends
Current periodCompared to+/- 
MRQ0.2%TTM0.2%0.0%
TTM0.2%YOY-2.6%+2.9%
TTM0.2%5Y7.3%-7.1%
5Y7.3%10Y7.3%0.0%
4.3.1.2. Return on Assets

Shows how efficient Piramal Pharma Limited is using its assets to generate profit.

  • Above 5% is considered healthy but always compare Piramal Pharma Limited to the Drug Manufacturers - Specialty & Generic industry mean.
  • 0.1% Return on Assets means that Piramal Pharma Limited generated ₹0.00 profit for each $1 in assets.

Let's take a look of the Return on Assets trends of Piramal Pharma Limited:

  • The MRQ is 0.1%. Using its assets, the company is inefficient in making profit. -1
  • The TTM is 0.1%. Using its assets, the company is inefficient in making profit. -1
Trends
Current periodCompared to+/- 
MRQ0.1%TTM0.1%0.0%
TTM0.1%YOY-1.3%+1.4%
TTM0.1%5Y3.5%-3.4%
5Y3.5%10Y3.5%0.0%
4.3.1.3. Return on Equity

Shows how efficient Piramal Pharma Limited is using its investors money to generate profit.

  • Above 15%-20% is considered healthy but always compare Piramal Pharma Limited to the Drug Manufacturers - Specialty & Generic industry mean.
  • 0.2% Return on Equity means Piramal Pharma Limited generated ₹0.00 for each ₹1 the owners (shareholders) invested.

Let's take a look of the Return on Equity trends of Piramal Pharma Limited:

  • The MRQ is 0.2%. Using its investors money, the company is inefficient in making profit. -1
  • The TTM is 0.2%. Using its investors money, the company is inefficient in making profit. -1
Trends
Current periodCompared to+/- 
MRQ0.2%TTM0.2%0.0%
TTM0.2%YOY-2.8%+3.0%
TTM0.2%5Y4.7%-4.5%
5Y4.7%10Y4.7%0.0%
3rd party ad coffee SUPPORTERis ad-free.

4.3.2. Operating Efficiency of Piramal Pharma Limited.

4.3.2. Operating Efficiency
4.3.2.1. Operating Margin

Measures how efficient Piramal Pharma Limited is operating .

  • Measures how much profit Piramal Pharma Limited makes for each ₹1 of sales after paying variable costs (production costs, wages, etc) but before taxes.
  • Above 15% is considered healthy but always compare Piramal Pharma Limited to the Drug Manufacturers - Specialty & Generic industry mean.
  • An Operating Margin of 5.6% means the company generated ₹0.06  for each ₹1 in revenue (before taxes).

Let's take a look of the Operating Margin trends of Piramal Pharma Limited:

  • The MRQ is 5.6%. The company is operating less efficient.
  • The TTM is 5.6%. The company is operating less efficient.
Trends
Current periodCompared to+/- 
MRQ5.6%TTM5.6%0.0%
TTM5.6%YOY3.3%+2.3%
TTM5.6%5Y5.5%+0.1%
5Y5.5%10Y5.5%0.0%
4.3.2.2. Operating Ratio

Measures how efficient Piramal Pharma Limited is keeping operating costs low.

  • Below 1 is considered healthy (always compare to Drug Manufacturers - Specialty & Generic industry mean).
  • An Operation Ratio of 0.94 means that the operating costs are ₹0.94 for each ₹1 in net sales.

Let's take a look of the Operating Ratio trends of Piramal Pharma Limited:

  • The MRQ is 0.944. The company is less efficient in keeping operating costs low.
  • The TTM is 0.944. The company is less efficient in keeping operating costs low.
Trends
Current periodCompared to+/- 
MRQ0.944TTM0.9440.000
TTM0.944YOY1.007-0.063
TTM0.9445Y0.925+0.019
5Y0.92510Y0.9250.000
3rd party ad coffee SUPPORTERis ad-free.

4.4.3. Liquidity of Piramal Pharma Limited.

4.4.3. Liquidity
4.4.3.1. Current Ratio

Measures if Piramal Pharma Limited is able to pay off Short-term Debt.

  • Above 1.5 is considered healthy (always compare to Drug Manufacturers - Specialty & Generic industry mean).
  • A Current Ratio of 1.25 means the company has ₹1.25 in assets for each ₹1 in short-term debts.

Let's take a look of the Current Ratio trends of Piramal Pharma Limited:

  • The MRQ is 1.251. The company is just able to pay all its short-term debts.
  • The TTM is 1.251. The company is just able to pay all its short-term debts.
Trends
Current periodCompared to+/- 
MRQ1.251TTM1.2510.000
TTM1.251YOY1.258-0.008
TTM1.2515Y1.250+0.000
5Y1.25010Y1.2500.000
4.4.3.2. Quick Ratio

Measures if Piramal Pharma Limited is able to pay off Short-term Debt but only using the most liquid assets.

  • Above 1 is considered healthy but always compare Piramal Pharma Limited to the Drug Manufacturers - Specialty & Generic industry mean.
  • A Quick Ratio of 0.67 means the company can pay off ₹0.67 for each ₹1 in debt (using most liquid assets).

Let's take a look of the Quick Ratio trends of Piramal Pharma Limited:

  • The MRQ is 0.665. The company is just not able to pay all its short-term debts with the most liquid assets. -1
  • The TTM is 0.665. The company is just not able to pay all its short-term debts with the most liquid assets. -1
Trends
Current periodCompared to+/- 
MRQ0.665TTM0.6650.000
TTM0.665YOY0.852-0.186
TTM0.6655Y1.008-0.342
5Y1.00810Y1.0080.000
3rd party ad coffee SUPPORTERis ad-free.

4.5.4. Solvency of Piramal Pharma Limited.

4.5.4. Solvency
4.5.4.1. Debt to Asset Ratio

Measures how much % of Piramal Pharma Limited assets are financed with debt.

  • Below 1 (100%) is considered healthy but always compare Piramal Pharma Limited to Drug Manufacturers - Specialty & Generic industry mean.
  • A Debt to Asset Ratio of 0.48 means that Piramal Pharma Limited assets are financed with 48.3% credit (debt) and the remaining percentage (100% - 48.3%) is financed by its owners/shareholders. 

Let's take a look of the Debt to Asset Ratio trends of Piramal Pharma Limited:

  • The MRQ is 0.483. The company is very able to pay all its debts by selling its assets. +2
  • The TTM is 0.483. The company is very able to pay all its debts by selling its assets. +2
Trends
Current periodCompared to+/- 
MRQ0.483TTM0.4830.000
TTM0.483YOY0.534-0.050
TTM0.4835Y0.400+0.083
5Y0.40010Y0.4000.000
4.5.4.2. Debt to Equity Ratio

Measures if Piramal Pharma Limited is able to pay off its debts by using shareholders equity.

  • Below 2 is considered healthy but always compare Piramal Pharma Limited to the Drug Manufacturers - Specialty & Generic industry mean.
  • A Debt to Equity ratio of 93.5% means that company has ₹0.94 debt for each ₹1 in shareholders equity.

Let's take a look of the Debt to Equity Ratio trends of Piramal Pharma Limited:

  • The MRQ is 0.935. The company is very able to pay all its debts with equity. +2
  • The TTM is 0.935. The company is very able to pay all its debts with equity. +2
Trends
Current periodCompared to+/- 
MRQ0.935TTM0.9350.000
TTM0.935YOY1.144-0.209
TTM0.9355Y0.726+0.209
5Y0.72610Y0.7260.000
3rd party ad coffee SUPPORTERis ad-free.

4.6. Market Valuation

4.6.1. Earnings Per Share
4.6.2.1. Price to Earnings Ratio

Measures how much money you pay for each share for every ₹1 in earnings Piramal Pharma Limited generates.

  • Above 15 is considered overpriced but always compare Piramal Pharma Limited to the Drug Manufacturers - Specialty & Generic industry mean.
  • A PE ratio of 954.69 means the investor is paying ₹954.69 for every ₹1 in earnings.

Let's take a look of the Price to Earnings Ratio trends of Piramal Pharma Limited:

  • The EOD is 1,852.724. Based on the earnings, the company is expensive. -2
  • The MRQ is 954.692. Based on the earnings, the company is expensive. -2
  • The TTM is 954.692. Based on the earnings, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD1,852.724MRQ954.692+898.032
MRQ954.692TTM954.6920.000
TTM954.692YOY-48.451+1,003.143
TTM954.6925Y226.560+728.132
5Y226.56010Y226.5600.000
4.6.2.2. Price To Free Cash Flow Ratio

Let's take a look of the Price To Free Cash Flow Ratio trends of Piramal Pharma Limited:

  • The EOD is -214.331. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The MRQ is -110.443. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The TTM is -110.443. Based on how much money comes from the company's main activities, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-214.331MRQ-110.443-103.888
MRQ-110.443TTM-110.4430.000
TTM-110.443YOY-18.788-91.655
TTM-110.4435Y-32.308-78.135
5Y-32.30810Y-32.3080.000
3rd party ad coffee SUPPORTERis ad-free.
4.6.2. Book Value per Share
4.6.2.1. Price to Book Ratio

Measures if the stock price of Piramal Pharma Limited is to cheap or to expensive compared to its book value.

  • At or below 1 is considered healthy (always compare to Drug Manufacturers - Specialty & Generic industry mean).
  • A PB ratio of 2.15 means the investor is paying ₹2.15 for each ₹1 in book value.

Let's take a look of the Price to Book Ratio trends of Piramal Pharma Limited:

  • The EOD is 4.173. Based on the equity, the company is fair priced.
  • The MRQ is 2.150. Based on the equity, the company is underpriced. +1
  • The TTM is 2.150. Based on the equity, the company is underpriced. +1
Trends
Current periodCompared to+/- 
EOD4.173MRQ2.150+2.023
MRQ2.150TTM2.1500.000
TTM2.150YOY1.334+0.817
TTM2.1505Y0.871+1.279
5Y0.87110Y0.8710.000
4.6.2. Total Gains per Share
3rd party ad coffee SUPPORTERis ad-free.

6. Financial Statements




6.1. Latest Balance Sheet

Balance Sheet of 2024-03-31. All numbers in thousands.

Summary
Total Assets153,118,100
Total Liabilities74,004,400
Total Stockholder Equity79,113,700
 As reported
Total Liabilities 74,004,400
Total Stockholder Equity+ 79,113,700
Total Assets = 153,118,100

Assets

Total Assets153,118,100
Total Current Assets54,644,700
Long-term Assets98,473,400
Total Current Assets
Cash And Cash Equivalents 4,825,600
Short-term Investments 1,446,900
Net Receivables 21,344,300
Inventory 21,758,800
Other Current Assets 5,269,100
Total Current Assets  (as reported)54,644,700
Total Current Assets  (calculated)54,644,700
+/-0
Long-term Assets
Property Plant Equipment 48,159,700
Goodwill 11,225,500
Intangible Assets 31,672,100
Long-term Assets Other 940,200
Long-term Assets  (as reported)98,473,400
Long-term Assets  (calculated)91,997,500
+/- 6,475,900

Liabilities & Shareholders' Equity

Total Current Liabilities43,693,000
Long-term Liabilities30,311,400
Total Stockholder Equity79,113,700
Total Current Liabilities
Short-term Debt 21,084,200
Accounts payable 15,383,700
Other Current Liabilities 6,822,100
Total Current Liabilities  (as reported)43,693,000
Total Current Liabilities  (calculated)43,290,000
+/- 403,000
Long-term Liabilities
Long-term Liabilities  (as reported)30,311,400
Long-term Liabilities  (calculated)0
+/- 30,311,400
Total Stockholder Equity
Common Stock13,229,500
Retained Earnings 9,706,700
Accumulated Other Comprehensive Income 65,884,200
Other Stockholders Equity -9,706,700
Total Stockholder Equity (as reported)79,113,700
Total Stockholder Equity (calculated)79,113,700
+/-0
Other
Cash and Short Term Investments 6,272,500
Common Stock Shares Outstanding 1,272,857
Current Deferred Revenue403,000
Liabilities and Stockholders Equity 153,118,100
Net Debt 42,276,000
Net Working Capital 10,951,700
Short Long Term Debt Total 47,101,600



6.2. Balance Sheets Structured

All numbers in thousands.

 Trend2024-03-312023-03-312022-03-312021-03-31
> Total Assets 
57,566,700
72,083,200
145,225,600
153,118,100
153,118,100145,225,60072,083,20057,566,700
   > Total Current Assets 
17,675,000
19,584,900
48,354,800
54,644,700
54,644,70048,354,80019,584,90017,675,000
       Cash And Cash Equivalents 
1,467,300
846,500
1,955,900
4,825,600
4,825,6001,955,900846,5001,467,300
       Short-term Investments 
156,400
393,800
6,315,000
1,446,900
1,446,9006,315,000393,800156,400
       Net Receivables 
16,081,200
18,086,100
18,143,500
21,344,300
21,344,30018,143,50018,086,10016,081,200
       Other Current Assets 
4,208,100
6,410,000
5,276,800
5,269,100
5,269,1005,276,8006,410,0004,208,100
   > Long-term Assets 
39,891,700
52,498,300
96,870,800
98,473,400
98,473,40096,870,80052,498,30039,891,700
       Property Plant Equipment 
13,845,700
14,652,400
44,414,500
48,159,700
48,159,70044,414,50014,652,40013,845,700
       Goodwill 
8,564,700
10,305,000
11,075,100
11,225,500
11,225,50011,075,10010,305,0008,564,700
       Intangible Assets 
3,632,400
3,487,400
33,382,200
31,672,100
31,672,10033,382,2003,487,4003,632,400
       Long-term Assets Other 
6,654,800
1,000
2,387,300
940,200
940,2002,387,3001,0006,654,800
> Total Liabilities 
16,560,500
21,409,800
77,490,600
74,004,400
74,004,40077,490,60021,409,80016,560,500
   > Total Current Liabilities 
14,716,700
15,171,400
38,430,500
43,693,000
43,693,00038,430,50015,171,40014,716,700
       Short-term Debt 
1,668,900
6,562,200
21,516,200
21,084,200
21,084,20021,516,2006,562,2001,668,900
       Accounts payable 
5,841,200
6,152,000
11,927,100
15,383,700
15,383,70011,927,1006,152,0005,841,200
       Other Current Liabilities 
64,400
107,000
2,289,200
6,822,100
6,822,1002,289,200107,00064,400
   > Long-term Liabilities 
1,843,800
6,238,400
39,060,100
30,311,400
30,311,40039,060,1006,238,4001,843,800
> Total Stockholder Equity
41,006,200
50,674,400
67,735,000
79,113,700
79,113,70067,735,00050,674,40041,006,200
   Common Stock
9,946,000
11,859,100
11,933,200
13,229,500
13,229,50011,933,20011,859,1009,946,000
   Retained Earnings 
5,690,400
8,623,800
9,564,400
9,706,700
9,706,7009,564,4008,623,8005,690,400
   Accumulated Other Comprehensive Income 
5,283,500
6,266,600
8,050,300
65,884,200
65,884,2008,050,3006,266,6005,283,500
   Capital Surplus 0000
   Treasury Stock0000
   Other Stockholders Equity 
20,086,300
23,924,900
38,187,100
-9,706,700
-9,706,70038,187,10023,924,90020,086,300



6.3. Balance Sheets

All numbers in thousands.




6.4. Cash Flows

All numbers in thousands.




6.5. Income Statements

All numbers in thousands.


6.6. Latest Income Statement

Income Statement (annual), 2024-03-31. All numbers in thousands.

Gross Profit (+$)
totalRevenue81,711,600
Cost of Revenue-57,240,700
Gross Profit24,470,90024,470,900
 
Operating Income (+$)
Gross Profit24,470,900
Operating Expense-19,914,000
Operating Income4,556,9004,556,900
 
Operating Expense (+$)
Research Development1,006,700
Selling General Administrative2,627,500
Selling And Marketing Expenses3,041,300
Operating Expense19,914,0006,675,500
 
Net Interest Income (+$)
Interest Income0
Interest Expense-4,484,900
Other Finance Cost-4,484,900
Net Interest Income0
 
Pretax Income (+$)
Operating Income4,556,900
Net Interest Income0
Other Non-Operating Income Expenses0
Income Before Tax (EBT)1,198,0007,915,800
EBIT - interestExpense = 72,000
1,792,900
4,663,100
Interest Expense4,484,900
Earnings Before Interest and Taxes (EBIT)4,556,9005,682,900
Earnings Before Interest and Taxes (EBITDA)11,962,600
 
After tax Income (+$)
Income Before Tax1,198,000
Tax Provision-0
Net Income From Continuing Ops01,198,000
Net Income178,200
Net Income Applicable To Common Shares0
 
Non-recurring Events
Discontinued Operations0
Extraordinary Items0
Effect of Accounting Charges0
Other Items0
Non Recurring0
Other Operating Expenses77,154,700
Total Other Income/Expenses Net-3,358,9000
 

Technical Analysis of Piramal Pharma Limited
The psychology behind the price

Technical indicators reflecting market sentiment and the collective psychology of you and other traders. Your emotions and other traders' emotions, such as fear and greed, play a significant role in driving price movements.

General trend

First of all, I'm going to put something in the back of your mind. One of the most stable factors that gives you more confidence as a trader: the general trend of Piramal Pharma Limited. The general trend of Piramal Pharma Limited is BULLISH with 85.7% confidence. It is very important for your mental being to use each indicator with this in mind. But beware, also the general trend flips once in a while! You can use moving averages to determine Piramal Pharma Limited's overall trend. For convenience I use the most commonly used moving averages: 20, 50, 100 & 200. Of course you can use other moving averages or other indicators to determine the trend.

Indicator phases

Some of the indicators I use have 3 zones: overbought, oversold and neutral. Transitions between these zones (market phases) provide valuable trading signals and insights. Expecially with the general trend mind, I use the highlighted phases:

Indicator zone transitionsBullish trend (85.7%) Bearish trend (-85.7%)
Overbought to neutralBullish pullback=Bearish reversal
Upper to lower neutralBullish correction=Bearish continuation
Nuetral to oversoldOversold=Oversold
Oversold to neutralBullish reversal=Bearish correction
Lower to upper neutralBullish continuation=Bearish pullback
Nuetral to overboughtOverbought=Overbought

1. Price Targets

1.1 Support & Resistance

Support and resistance are levels on a price chart that act as barriers or zones where the price of an asset tends to stop, reverse, or experience a significant amount of buying or selling pressure.

Support is a price level at which demand for an asset is strong enough to prevent the price from falling further.
Resistance is a price level at which selling pressure becomes significant enough to prevent the price of an asset from rising further.


Score

Let's take a look at the Support & Resistance of Piramal Pharma Limited.

The long score for the Support & Resistance is 1/1.
The longshort score for the Support & Resistance is 1/(-1 +1).

  • Around support: The price is currently trading around a support level. This can be considered as a potential entry level. +1

The bullish price targets are: 307.90.

The bearish price targets are: 243.99 > 235.42 > 209.50.

Tweet this
Piramal Pharma Limited Daily Support & Resistance Chart

2. Trend Indicators

2.1 Moving Averages

Shows the moving average of the selected period.

  • Moving averages are lagging trend indicators.
  • There are many types of moving averages.
  • Moving averages are also used within other indicators.

Score

Let's take a look at the Moving Averages of Piramal Pharma Limited. The current mas is .

The long score for the Moving Averages is 13/14.
The longshort score for the Moving Averages is 12/(-14 +14).

  • MA 20 trending up: The MA 20 is trending up. +1
  • Close < MA 20: The price is below the MA 20. -1
  • MA 20 > MA 50: The MA 20 is higher than the MA 50. +1
  • MA 20 > MA 100: The MA 20 is higher than the MA 100. +1
  • MA 20 > MA 200: The MA 20 is higher than the MA 200. +1
  • MA 50 trending up: The MA 50 is trending up. +1
  • Close > MA 50: The price is above the MA 50. +1
  • MA 50 > MA 100: The MA 50 is higher than the MA 100. +1
  • MA 50 > MA 200: The MA 50 is higher than the MA 200. +1
  • MA 100 trending up: The MA 100 is trending up. +1
  • Close > MA 100: The price is above the MA 100. +1
  • MA 100 > MA 200: The MA 100 is higher than the MA 200. +1
  • MA 200 trending up: The MA 200 is trending up. +1
  • Close > MA 200: The price is above the MA 200. +1

Directionalities and relatives.

Moving AverageAmount of candlesTrendPrice +/-vs. MA 50vs. MA 100vs. MA 200
MA 2020
MA 5050-
MA 100100--
MA 200200---

Explanation: https://www.youtube.com/watch?v=xwW8h0lrQ-I

Piramal Pharma Limited Daily Moving Averages Chart
2.2 Moving Average Convergence/Divergence (MACD)

Shows the momentum of the selected period based on two moving averages.

  • MACD is a lagging momentum indicator.
  • Uses two moving averages.
  • Can show buy or sell signals based on momentum.
  • Can show overbought. and oversold. levels.

Score

Let's take a look at the Moving Average Convergence/Divergence (MACD) of Piramal Pharma Limited. The current macd is 4.45960199.

The long score for the Moving Average Convergence/Divergence (MACD) is 1/4.
The longshort score for the Moving Average Convergence/Divergence (MACD) is -2/(-4 +4).

  • MACD line < signal line: The MACD line is below the signal line, which indicates a bearish signal in the market. This means that the negative momentum is currently stronger than the average momentum, suggesting that sellers are more active than buyers, and there's a higher probability of the Piramal Pharma Limited price going down in the near term. -2
  • MACD > 0: The MACD is above the zero line (centerline), it indicates a bullish signal for Piramal Pharma Limited. This means that the short-term moving average is higher than the long-term moving average, signaling positive momentum and suggesting a higher likelihood of the Piramal Pharma Limited price continuing to rise in the near future. It indicates that buyers are gaining control, and there is optimism in the market, leading to potential price increases. +1
  • Trending down: The MACD line is trending down. This indicates that the short-term moving average is falling faster than the long-term moving average, suggesting negative momentum in the market. This signals that sellers are becoming more active and insecure, leading to potential price decreases as traders anticipate further losses and are willing to sell at lower prices. -1
Piramal Pharma Limited Daily Moving Average Convergence/Divergence (MACD) ChartPiramal Pharma Limited Daily Moving Average Convergence/Divergence (MACD) Chart
2.3 Directional Movement Index (DMI)

The DMI is a collection of 3 indicators: +DI (Plus Direction Indicator), -DI (Minus Direction Indicator) and ADX (Average Directional Index). The ADX helps you determine the strength of a trend.


Score

Let's take a look at the Directional Movement Index (DMI) of Piramal Pharma Limited. The current adx is 28.51.

The long score for the Directional Movement Index (DMI) is 3/7.
The longshort score for the Directional Movement Index (DMI) is 3/(-7 +7).

  • PLUS_ID > MINUS_DI: The +DI line is above the -DI line. This indicates a bullish signal in the market, as the positive directional movement is currently stronger than the negative directional movement, showing that buyers have the upper hand. Market psychology suggests that traders are optimistic, expecting further price increases, and are more willing to buy Piramal Pharma Limited shares, leading to potential upward momentum in its price. +1
  • PLUS_ID > MINUS_DI && ADX > 25 && ADX trending down: The ADX is above 25 and indicates a strong bullish trend. The ADX is declining, the bullish trend is weakening. Could be a potential reversal to the downside. +2
Piramal Pharma Limited Daily Directional Movement Index (DMI) Chart
2.4 Parabolic SAR

Shows the current trend and potential entry and exit signals.

  • Parabolic SAR (stop and reverse) is a lagging trend indicator.
  • Shows the current trend.
  • Shows potential entry signals.
  • Shows  potential exit signals.
  • Can be used to place trailing stoplosses..

Score

Let's take a look at the Parabolic SAR of Piramal Pharma Limited. The current sar is 292.06.

The long score for the Parabolic SAR is 0/1.
The longshort score for the Parabolic SAR is -1/(-1 +1).

  • Close < SAR: The price is below the SAR. It's generally considered a bearish signal. -1
Piramal Pharma Limited Daily Parabolic SAR Chart
3rd party ad coffee SUPPORTERis ad-free.

3. Momentum Indicators

3.1 Relative Strength Index (RSI)

Measures the speed and change of price movements.

  • Leading momentum indicator, meaning the signals are instant.
  • Ranges between 0 and 100.
  • Above 70 is considered overbought.
  • Below 30 is considered oversold.
  • Above or below 50 can also be used to determine price trend or support and resistance.
  • RSI divergence looks at a deviation between RSI and price movement. Penketrading automatically calculates RSI divergences.
  • Can be used in many different ways

Score

Let's take a look at the Relative Strength Index (RSI) of Piramal Pharma Limited. The current rsi is 49.11. The current phase is Correction in bull market.

The long score for the Relative Strength Index (RSI) is 1/13.
The longshort score for the Relative Strength Index (RSI) is -2/(-13 +13).

  • Correction in bull market: Moderate price decline, potential pause in the uptrend. Reassess the market, wait for signs of stabilization.
  • Trending up: The RSI is trending up. +1
Piramal Pharma Limited Daily Relative Strength Index (RSI) ChartPiramal Pharma Limited Daily Relative Strength Index (RSI) Chart
3.2 Stochastic Oscillator

Compares a certain price to multiple prices ranging over time.

  • Leading momentum indicator, meaning the signals are instant.
  • Used to determine overbought and oversold areas much like the RSI.
  • Ranges between 0 and 100.
  • Above 80 is considered overbought.
  • Below 20 is considered oversold.
  • Consists of two lines named K and D.
  • K compares the highest high and lowest low on the selected price range.
  • The D line is a moving average of the K line.
  • Can be used to spot divergences

Score

Let's take a look at the Stochastic Oscillator of Piramal Pharma Limited. The current phase is Oversold in bull market.

The long score for the Stochastic Oscillator is 3/6.
The longshort score for the Stochastic Oscillator is 0/(-6 +6).

  • STOCH < 50: The STOCH %K is below 50. There are more sellers than buyers. -1
  • STOCH < 20: The STOCH %K is below 20 and oversold. -2
  • STOCH %K line > STOCH %D line: The STOCH %K line is above the STOCH %D line, which indicates a bullish signal in the market. This means that the positive momentum is currently stronger than the average momentum, suggesting that buyers are more active than sellers, and there's a higher probability of the Piramal Pharma Limited price going up in the near term. +2
  • Trending up: The STOCH %K is trending up. +1
Piramal Pharma Limited Daily Stochastic Oscillator ChartPiramal Pharma Limited Daily Stochastic Oscillator Chart
3.3 Commodity Channel Index (CCI)

Measures the difference between the current price and the historical average price.

  • Lagging or leading Momentum indicator
  • When the CCI is above zero, the price is above the historical average
  • When the CCI is below zero, the price is below the historical average
  • Used for spotting trends
    • If the CCI moves from negative or near zero to positive 100 that might indicate an uptrend
    • If the CCI moves from positive or near zero to negative -100 that might indicate a downtrend

Score

Let's take a look at the Commodity Channel Index (CCI) of Piramal Pharma Limited. The current cci is -68.91765265.

Piramal Pharma Limited Daily Commodity Channel Index (CCI) ChartPiramal Pharma Limited Daily Commodity Channel Index (CCI) Chart
3.4 Chande Momentum Oscillator (CMO)

Measures the difference between the sum of recent gains and the sum of recent losses. Then divides the result by the sum of all price movements in that period.

  • Lagging momentum indicator
  • Ranges between +100 and -100
  • Considered overbought above +50
  • Considered oversold below -50
  • It's possible to add a moving average that acts as a signal line

Score

Let's take a look at the Chande Momentum Oscillator (CMO) of Piramal Pharma Limited. The current cmo is -10.92658146.

The long score for the Chande Momentum Oscillator (CMO) is 0/1.
The longshort score for the Chande Momentum Oscillator (CMO) is -1/(-1 +1).

  • CMO < 0: The CMO is below 0, the momentum of the price is negative, indicating a potential downtrend in the price. -1
Piramal Pharma Limited Daily Chande Momentum Oscillator (CMO) ChartPiramal Pharma Limited Daily Chande Momentum Oscillator (CMO) Chart
3.5 Williams %R

 Shows the current price relative to the highest high over the last 14 days.
 

  • Lagging momentum indicator
  • Ranging between 0 and -100
  • Above -20 is considered overbought
  • Below -80 is considered oversold
  • Is prone to give false signals

Score

Let's take a look at the Williams %R of Piramal Pharma Limited. The current willr is -90.51724138.

The long score for the Williams %R is 0/1.
The longshort score for the Williams %R is -1/(-1 +1).

  • WILLR < -80: The Williams %R is below -80. This indicates that the price is in oversold territory, suggesting a potential price correction or trend reversal to the upside. -1
Piramal Pharma Limited Daily Williams %R ChartPiramal Pharma Limited Daily Williams %R Chart
3rd party ad coffee SUPPORTERis ad-free.

4. Volatility Indicators

4.1 Bollinger Bands

Shows if the price is to high or to low relative to an average.

  • Lagging volatility indicator
  • Uses 3 bands: one upper, one lower and one in the middle
  • Works best when the middle band reflects an intermediate trend (MA20).
  • When the price is moving closer to the upper band, the market might be overbought
  • When the price is moving closer to the lower band, the market might be oversold 

Score

Let's take a look at the Bollinger Bands of Piramal Pharma Limited.

Piramal Pharma Limited Daily Bollinger Bands Chart
4.2 Average True Range (ATR)
Measures market volatility
  • Leading volatility indicator
  • Can be used to determine stop-loss positions
  • Calculated by:
    • Current high minus the current low
    • Current high minus the previous close
    • Current low minus the previous close
  • The larger the range of the candles, the greater the ATR value

Score

Let's take a look at the Average True Range (ATR) of Piramal Pharma Limited. The current atr is 14.43.

Piramal Pharma Limited Daily Average True Range (ATR) ChartPiramal Pharma Limited Daily Average True Range (ATR) Chart
3rd party ad coffee SUPPORTERis ad-free.

5. Volume Indicators

5.1 On-Balance Volume (OBV)

 Measures market volatility

  • Leading momentum indicator
  • Calculation:
    • If the closing price is above the previous closing price: OBV = previous OBV + current volume
    • If the closing price is below the previous closing price: OBV = previous OBV - current volume
    • If the closing price is the same as the previous closing price than the OBV is the same.
  • Can be used to confirm price trends
  • Can be used with divergences

Score

Let's take a look at the On-Balance Volume (OBV) of Piramal Pharma Limited. The current obv is 1,071,110,753.

Piramal Pharma Limited Daily On-Balance Volume (OBV) ChartPiramal Pharma Limited Daily On-Balance Volume (OBV) Chart
5.2 Money Flow Index (MFI)

Measures the flow of money in and out of a security

  • Lagging momentum indicator
  • Looks like RSI but uses volume as an extra metric (RSI only considers price)
  • Above 80 is considered overbought
  • Below 20 is considered oversold
  • Can be used with divergences

Score

Let's take a look at the Money Flow Index (MFI) of Piramal Pharma Limited. The current mfi is 75.08.

The long score for the Money Flow Index (MFI) is 1/2.
The longshort score for the Money Flow Index (MFI) is 1/(-2 +2).

  • MFI > 50: +1
Piramal Pharma Limited Daily Money Flow Index (MFI) ChartPiramal Pharma Limited Daily Money Flow Index (MFI) Chart
3rd party ad coffee SUPPORTERis ad-free.

6. Summary

6.1. Notifications

TypeNotificationDate
PenkeCurrently no notifications for Piramal Pharma Limited.

6.2. Trading Signals

Below you will find trading signals as the indicator is commonly used. This doesn't mean you should use it that way. Learn from these, but don't use them blindly. I recommend using at least 4 indicators, 1 from each category: trend, momentum, volatility and volume.

DateIndicatorSignal
2024-07-02STOCH SHORT EXITThe %K line crosses above the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-07-03STOCH LONG EXITThe %K line crosses below the %D line.
2024-07-04MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
2024-07-08CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-07-10DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-07-11WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2024-07-15DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
STOCH SHORT EXITThe %K line crosses above the %D line.
2024-07-18STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-07-19DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2024-07-22DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
STOCH SHORT EXITThe %K line crosses above the %D line.
2024-07-23CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-07-24MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-07-26STOCH LONG EXITThe %K line crosses below the %D line.
2024-07-29STOCH SHORT EXITThe %K line crosses above the %D line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2024-08-01RSI SHORT ENTRY LONG CLOSE70 crossover to downside
STOCH LONG EXITThe %K line crosses below the %D line.
2024-08-05RSI SHORT ENTRY LONG CLOSE70 crossover to downside
2024-08-07STOCH SHORT EXITThe %K line crosses above the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-08-09RSI SHORT ENTRY LONG CLOSE70 crossover to downside
STOCH LONG EXITThe %K line crosses below the %D line.
2024-08-12STOCH SHORT EXITThe %K line crosses above the %D line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-08-13STOCH LONG EXITThe %K line crosses below the %D line.
2024-08-14RSI SHORT ENTRY LONG CLOSE70 crossover to downside
MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2024-08-20STOCH SHORT EXITThe %K line crosses above the %D line.
2024-08-22WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-08-23STOCH LONG EXITThe %K line crosses below the %D line.
2024-08-26MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
2024-08-29WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-08-30STOCH SHORT EXITThe %K line crosses above the %D line.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-09-02SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-09-03RSI SHORT ENTRY LONG CLOSE70 crossover to downside
2024-09-04MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2024-09-09STOCH LONG EXITThe %K line crosses below the %D line.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-09-10WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-09-11STOCH SHORT EXITThe %K line crosses above the %D line.
2024-09-12STOCH LONG EXITThe %K line crosses below the %D line.
2024-09-17STOCH SHORT EXITThe %K line crosses above the %D line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-09-18RSI SHORT ENTRY LONG CLOSE70 crossover to downside
STOCH LONG EXITThe %K line crosses below the %D line.
2024-09-19SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
2024-09-20MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
2024-09-24CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2024-09-25STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-09-27STOCH LONG EXITThe %K line crosses below the %D line.
2024-09-30STOCH SHORT EXITThe %K line crosses above the %D line.
2024-10-03STOCH LONG EXITThe %K line crosses below the %D line.
2024-10-04STOCH SHORT EXITThe %K line crosses above the %D line.
2024-10-07STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-10-08STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-10-10DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-10-11STOCH SHORT EXITThe %K line crosses above the %D line.
2024-10-14DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
2024-10-15SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-10-16CCI LONG ENTRY SHORT CLOSE100 crossover to upside
2024-10-17STOCH LONG EXITThe %K line crosses below the %D line.
2024-10-21STOCH SHORT EXITThe %K line crosses above the %D line.
2024-10-22DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-10-24MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
STOCH SHORT EXITThe %K line crosses above the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2024-10-25MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2024-10-28STOCH LONG EXITThe %K line crosses below the %D line.
2024-10-29STOCH SHORT EXITThe %K line crosses above the %D line.
2024-10-31WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2024-11-04STOCH LONG EXITThe %K line crosses below the %D line.
2024-11-05RSI SHORT ENTRY LONG CLOSE70 crossover to downside
2024-11-06BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-11-08RSI SHORT ENTRY LONG CLOSE70 crossover to downside
2024-11-12MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-11-18WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-11-19MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2024-11-22STOCH SHORT EXITThe %K line crosses above the %D line.

6.3. Candlestick Patterns

Piramal Pharma Limited Daily Candlestick Chart
DateCandlestick Pattern

6.4. Technical Score

Let's check the technical score of Piramal Pharma Limited based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5049.107
Ma 20Greater thanMa 50262.034
Ma 50Greater thanMa 100239.891
Ma 100Greater thanMa 200208.041
OpenGreater thanClose248.300
Total3/5 (60.0%)
Penke
Good job! You gained 25 XP and 0   0   10 . What's next:
  • Share my analysis of Piramal Pharma Limited with someone you think should read this too:
  • Are you bullish or bearish on Piramal Pharma Limited? Let me know what you think in the comments.
  • Do you want an email if I find something interesting about Piramal Pharma Limited? Add an email alert using the form below.
  • Join the community if you want to keep your earnings and track your progress: Join the community
  • Is this analysis useful to you? Support me via But Me a Coffee. I'll analyze the stock market faster for you!

Get notifications about Piramal Pharma Limited

I send you an email if I find something interesting about Piramal Pharma Limited.


Comments

How you think about this?

Leave a comment

Stay informed about Piramal Pharma Limited.

Receive notifications about Piramal Pharma Limited in your mailbox!

3rd party ad coffee SUPPORTERis ad-free.